Mostrando 7 resultados de: 7
Filtros aplicados
Subtipo de publicación
Article(7)
Publisher
International Journal of Tuberculosis and Lung Disease(3)
Vaccine(2)
BMC Medicine(1)
Controlled Clinical Trials(1)
Área temáticas
Enfermedades(6)
Medicina forense; incidencia de enfermedades(6)
Problemas sociales y servicios a grupos(2)
Bioquímica(1)
Farmacología y terapéutica(1)
Origen
scopus(7)
A comparison of dual skin test with mycobacterial antigens and tuberculin skin test alone in estimating prevalence of Mycobacterium tuberculosis infection from population surveys
ArticleAbstract: SETTING: City of Manaus, Amazonas, Brazil. OBJECTIVE: To compare estimates of Mycobacterium tuberculPalabras claves:BCG, Brazil, Dual skin test, PREVALENCE, Sensitin, TuberculinAutores:Bierrenbach A.L., Cunha S.S., Dourado M.I., Floyd S., Hijjar M.A., Mauricio L. Barreto, Pereira S.M., Rodrigues L.C.Fuentes:scopusCauses of variation in BCG vaccine efficacy: Examining evidence from the BCG REVAC cluster randomized trial to explore the masking and the blocking hypotheses
ArticleAbstract: BCG protection varies and in some places (nearest the equator) is low or absent. Understanding thisPalabras claves:BCG, Blocking, Efficacy, Geographical variation, Masking, PROTECTION, Tuberculosis, VaccineAutores:Cruz A.A., Cunha S.S., Genser B., Hijjar M.A., Ichihara M.Y.T., Mauricio L. Barreto, Pereira S.M., Pilger D., Rodrigues L.C., Sant'Anna C.C.Fuentes:scopusDesign of the Brazilian BCG-REVAC trial against tuberculosis: A large, simple randomized community trial to evaluate the impact on tuberculosis of BCG revaccination at school age
ArticleAbstract: This paper describes the design and baseline results of a large and simple randomized controlled triPalabras claves:Bacillus Calmette-Guérin, BCG, Brazil, Cluster randomization, Protective effect, Randomized clinical trial, Revaccination, TuberculosisAutores:Cunha S.S., De Brito S., Dourado M.I., Hijjar M.A., Ichihara M.Y.T., Mauricio L. Barreto, Pereira S.M., Rodrigues L.C.Fuentes:scopusEvidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: Second report of the BCG-REVAC cluster-randomised trial
ArticleAbstract: BCG revaccination is still used in some tuberculosis endemic countries. Until now, the little evidenPalabras claves:BCG, Revaccination, School age, Tuberculosis, Vaccine efficacyAutores:Cruz A.C., Cunha S.S., Genser B., Ichihara M.Y.T., Mauricio L. Barreto, Pereira S.M., Pilger D., Rodrigues L.C., Sant'Anna C.C.Fuentes:scopusNeonatal BCG protection against tuberculosis lasts for 20 years in Brazil
ArticleAbstract: Bacille Calmette-Guérin (BCG) efficacy against pulmonary disease is highly variable; until very recePalabras claves:BCG, Neonatal effect, TuberculosisAutores:Cruz A.C., Cunha S.S., De Brito S., Dourado M.I., Genser B., Hijjar M.A., Ichihara M.Y.T., Mauricio L. Barreto, Pereira S.M., Rodrigues L.C., Santa'Ana C.Fuentes:scopusPrevious BCG vaccination is associated with less severe clinical progression of COVID-19
ArticleAbstract: Background: BCG vaccination, originally used to prevent tuberculosis, is known to “train” the immunePalabras claves:Bacillus Calmette-Guérin, BCG, coronavirus disease 2019, covid-19, SARS-COV-2, severity, VaccinationAutores:Abubakar I., Barral-Netto M., Barreto F.R., da Natividade M.S., da Paixão E.S., Dalcolmo M., de Alencar Ximenes R.A., de Andrade K.V.F., de Britto E.A., de Jesus Lima C.C.O., de Souza F.M., de Souza R.A., de Souza Teles Santos C.A., Fernandes E.G., Ichihara M.Y., Junior E.B.C., Lindoso A.A.B.P., Mauricio L. Barreto, Nunes C., Pereira M., Pereira S.M., Pescarini J.M., Rodrigues L.C., Trajman A.Fuentes:scopusSkin test reactivity to mycobacterial antigens parallels the phylogenetic structure of their genus
ArticleAbstract: SETTING: City of Manaus, Amazonas, Brazil. OBJECTIVE: To explore the relationship between positivityPalabras claves:BCG, Brazil, Dual skin test, PPD, Sensitin, TuberculinAutores:Bierrenbach A.L., Cunha S.S., Mauricio L. Barreto, Pereira S.M., Rodrigues L.C.Fuentes:scopus